![](/store/_ui/responsive/theme-master/images/program-default-image-1200x600.png)
![](/store/_ui/responsive/theme-master/images/program-default-image-1200x600.png)
Frenchay Dysarthria Assessment 2 Edition
FDA-2- Measurement, differential description, and diagnosis of dysarthria
- PCTA distributes but does not publish this product.
Choose from our formats
-
Kits
Starter & complete kits, print & digital
1 option
From AUD 422.62 -
Test forms & reports
Booklets, record forms, answer sheets, report usages & subscriptions
1 option
From AUD 128.92 -
Support materials
Manuals, stimulus books, replacement items & other materials
1 option
From AUD 131.12 -
All products
All tests and materials offered for FDA-2
3 options
From AUD 128.92
-
FDA 2 Complete Kit
12685 Qualification Level BIncludes:
- Examiners Manual
- 25 Rating Forms
- Intelligibility Cards
-
FDA-2 Rating Forms
12687 Qualification Level BPack of 25
Estimated to ship:More than 12 weeks -
FDA-2-Intelligibility Cards
12688 Qualification Level BEstimated to ship:More than 12 weeks
Overview
- Publication date:
- 2008
- Completion time:
- 20 minutes
- Administration:
- Individual
- Age range:
- 12 years to adult
- Qualification level:
- B
Product Details
The second edition of Frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis. This updated edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria. It can be used in research, as well as all clinical settings. FDA-2 is quick and simple to administer, accurate, reliable, and cost-efficient. The client is rated on a number of simple performance tasks related to speech function. It is divided into eight sections:
The test results can be recorded on the FDA-2 Rating Form, indicating both the clients strengths and weaknesses. The Rating Form also allows the clinician to compare the clients performance across all the items. Normative data are reported for adults without dysarthria as well as patients with specific dysarthria associated with confirmed medical diagnoses. |